Editorial
We have a new policy at JHL; we will no longer publish any research funded by companies that are not compliant with the International Code of Marketing of Breast-milk Substitutes. 1 ILCA has had this policy for some time; however, JHL has not. In reviewing the policies and procedures in place when I took over the editorship, this one stuck out as incongruent with the way our professional organization and IBCLCs everywhere practice. Since the responsibility for journal policies falls solely on the editor-in-chief, I made this policy decision after consulting with researchers and clinicians in our field. It is an ethical stance congruent with the values of our profession, which this journal serves. You may have noticed the announcement of this policy change in the Table of Contents in your last issue of JHL. There has been a lot of positive feedback about this change coming from researchers, scholars, and IBCLCs. However, not everyone has been supportive of the decision. Since I made this decision, there have been those who felt it was not an appropriate thing to do.
Voices opposed to this new policy stated that the journal has been clearly identifying funding sources, which should be sufficient to let readers evaluate possible bias. Although this may be true for the experts in research methodology who read JHL, it may not be true for all of our readers. JHL needs to serve all of our readers. Publishing authors' conflict of interest statements are a minimum standard for professional journals, not the gold standard for our profession.
Other opposing voices have highlighted the high quality of some of the research done because non-International Code compliant funding was available, which might not have been done otherwise. It is not the intent of this policy to judge the quality of any research completed with non-International Code compliant funding. I know that quality studies completed by leaders in our field that have been funded by non-International Code compliant companies exist. As some have said, this quality non-International Code compliant research needs to be published somewhere: Why not JHL? The answer is simple. We serve IBCLCs, who have a Code of Professional Conduct 2 clearly identifying their relationship with non-International Code compliant companies. The research you see published in JHL may be slightly different because of this decision.
Publishing research funded by those who might benefit from the work being published continues to be a hot topic in the publishing world. It has been widely discussed by editors of professional journals for many years. In 2013, after many years of debate on the topic, the editors of the British Medical Journal (BMJ) decided to no longer publish research funded by tobacco money. 3 Their reasoning was similar to mine, citing that their purpose was to promote health, and commercial entities, no matter how well intentioned, have a different bottom line, which may influence all the work they sponsor. Currently, the debate among BMJ readers and editors has focused on whether to accept manuscripts funded by pharmaceutical companies. 4 Once again, their reasoning takes an ethical stance that questions the underlying intent of such funding.
Some breastfeeding-focused journals have similar policies, whereas others do not. It is time that those who promote and support breastfeeding families step up and walk the talk instead of promoting breastfeeding on one hand and promoting formula company research on the other. 
Editor's Note

Style change
The style format for JHL will be changing to the American Psychological Association (6th Edition), as of the February 2017 issue. Therefore any manuscripts submitted after July 15, 2016 must be formatted in this style to be accepted for review.
